The effect of Colestimide on the lowering activity of LDL-C and visceral fat in patients with hypercholesterolemia
Not Applicable
- Conditions
- hypercholesterolemia
- Registration Number
- JPRN-UMIN000001621
- Lead Sponsor
- The study group of the treatment for atherosclerotic diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who are administered statins except Pravastatin. 2)Patients who are administered insulin. 3)Patients who are administered steroid. 4)Patients who started treatment for diabetes or hyperlipidemia within 3 month before entry. 5)Patients with complete biliary obstruction. 6)Patients who have a history of hypersensitivity for Colestimide. 7)Patients with intestinal obstruction. 8)Patients who are underwent hormone replacement therapy. 9)Patients with hyper- or hypothyroidism. 10)Patients who are pregnant or lactating. 11)Patients who are judged to be inadequate to participate in this study by their physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The difference in the visceral fat area after the administration of Colestimide for 24 weeks
- Secondary Outcome Measures
Name Time Method Waist circumference Body weight Blood pressure Serum levels of lipid Plasma levels of adipocytokine Glucose metabolism marker